Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, et al
Engineered antimicrobial peptides for eczema Given the potential to manage the skin microbiome, fight infections, and modulate local immune responses simultaneously, antimicrobial peptides from diverse origins have become one of the most promising alternative solutions for atopic dermatitis management
The early trial data is hard to ignore
We work closely with authorities and regulatory bodies from around the world to continuously monitor the safety profile of our products. The EU patient leaflets for Wegovy, Ozempic and Rybelsus had been updated to include Naion, they added, but based on the totality of evidence, we concluded that the data did not suggest a reasonable possibility of a causal relationship between semaglutide and Naion and Novo Nordisk believes that the benefit-risk profile of semaglutide remains favourable.